Design and Operational Challenges in Psychedelic Clinical Trials
Categories:
Prescription Medicines, Events
Marion Coe, PhD, Director, Clinical Development and Postmarketing Surveillance, Pinney Associates
Presented as part of the session Hot Topics in Psychedelic Drug Development: From Successful Clinical Trials to Maximizing Benefits in the Post-approval World, May 5, 2021
